Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Used together, they may help support a deeper understanding and a more complete treatment plan
Good newsthere's no downtime needed
Phenome-based approach identifies RIC1-linked Mendelian syndrome through zebrafish models, biobank associations and clinical studies
A., Wei, W., Irannejad, R
A new study suggests that the diabetes drug Farxiga may be ineffective at treating patients with acute organ dysfunction, such as kidney injuries, raising concerns about the off-label use of the popular treatment
GLP-1/GIP medications have strong clinical trial evidence for average weight loss and are FDA-approved for chronic weight management under specific criteria, while lipotropic injections have limited evidence as a weight-loss treatment
US$ 27.58
US$ 25.21
US$ 23.89
US$ 27.51
